Alteration of p16 and p15 genes in common epithelial ovarian tumors

International Journal of Cancer

Volumn 74, Issue 2, 1997, Pages 148-155

  Fujita, Masami ^a   Enomoto, Takayuki ^a   Haba, Tomoko ^b   Nakashima, Ryuichi ^a   Sasaki, Makoto ^b   Yoshino, Kiyoshi ^a   Wada, Hiroko ^a   Buzard, Gregory S ^c   Matsuzaki, Noboru ^a   Wakasa, Kenichi ^b   Murata, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P15; PROTEIN P16; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ACTINS; ADENOCARCINOMA, MUCINOUS; CARCINOMA, ENDOMETRIOID; CARRIER PROTEINS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYSTADENOCARCINOMA, SEROUS; FEMALE; GENE DELETION; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0030922573     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970422)74:2<148::AID-IJC2>3.0.CO;2-Z     Document Type: Article

References (34)

1. ARZIMANOGLOU, I.I., LALLAS, T., OSBORNE, M., BARBER, H. and GILBERT, F., Microsatellite instability differences between familial and sporadic ovarian cancers. Carcinogenesis, 17, 1799-1804 (1996).
2. BERCHUCK, A., and 12 OTHERS, Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res., 50, 4087-4091 (1990).
3. EHLEN, T. and DUBEAU, L., Loss of heterozygosity on chromosomal segments 3p, 6q, and 11p in human ovarian carcinomas. Oncogene, 5, 219-223 (1990).
4. ENOMOTO, T., FUJITA, M., CHENG, C., NARASHIMA, R., OZAKI, M., INOUE, M. and NOMURA, T., Loss of expression and loss of heterozygosity in the DCC gene in neoplasms of the human female reproductive tract. Brit. J. Cancer, 71, 462-467 (1995).
5. ENOMOTO, T., FUJITA, M., INOUE, M., NAKAZAWA-MIYAMOTO, A., TANIZAWA, O. and NOMURA, T., Alterations of the Rb gene and its association with K-ras activation and p53 inactivation in endometrial adenocarcinoma. Mol. Carcinogenesis, 8, 132-137 (1993).
6. ENOMOTO, T., WEGHORST, C.M., INOUE, M., TANIZAWA, O. and RICE, J.M., K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary. Amer. J. Pathol., 139, 777-785 (1991).
7. FUJITA, M., ENOMOTO, T., INOUE, M., OZAKI, M., RICE, J.M., NOMURA, T. and TANIZAWA, T., Alteration of the p53 tumor suppressor gene occurs more frequently in serous adenocarcinomas than other common epithelial tumors of the human ovary. Jpn. J. Cancer Res., 85, 1247-1256 (1994).
8. FUJITA, M., ENOMOTO, T., YOSHINO, K., NOMURA, T., BUZARD, G.S., INOUE, M. and OKUDAIRA, Y., Microsatellite instability and alterations in the hMSH2 gene in human ovarian cancer. Int. J. Cancer, 64, 361-366 (1995).
9. GONZALEZ-ZULUETA, M., BENDER, C.M., YANG, A.S., NGUYEN, T., BEART, R. W., VAN TURNOUT, J.M. and JONES, P.A., Methylation of the 5′CpG island of the P16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55, 4531-4535 (1995).
10. INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev., 8, 2939-2952 (1994).
11. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature (Lond.), 371, 257-261 (1994).
12. HATTA, Y., HIRAMA, T., TAKEUCHI, S., LEE, E., PHAM, E., MILLER, C.W., STROHMEYER, T., WILCZYNSKI, S.P., MELMED, S. and KOEFFLER, H.P., Alterations of the p16 (MTS1) gene in testicular, ovarian, and endometrial malignancies. J. Urol., 154, 1954-1957 (1995).
13. HENGSTSCHLÄGER, M., HENGSTSCHLÄGER, O.E., PUSCH, O. and WAWARA, E., The role of p16 in the E2F-dependent thymidine kinase regulation. Oncogene, 12, 1635-1643 (1996).
14. INK4BI. Cancer Res., 56, 722-727 (1996).
15. HERMAN, J.G., MERLO, A., MAO, L., LAPIDUS, R.G., ISSA, J.-P.J., DAVIDSON, N.E., SIDRANSKY, D. and BAYLIN, S.B., Inactivation of the CDKN2/p16/ MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-1530 (1995).
16. JEN, J., HARPER, J.W., BIGNER, S.H., EIGNER, D.D., PAPADOPOULOS, N., MARKOWITZ, S., WILLSON, J.K.V. KINZLER, K.W. and VOGELSTEIN, B., Detection of p16 and p15 genes in brain tumors. Cancer Res., 54, 6353-6358 (1994).
17. JENKINS, R.B., BARTELT, D., JR., STALBOERGER, P., PERSONS, D., DAHL, R.J., PODRATZ, K., KEENEY, G. and HARTMANN, L., Cytogenetic studies of epithelial ovarian carcinoma. Cancer Genet Cytogenet., 71, 76-86 (1993).
18. KAMB, A., GRUIS, N.A., WEAVER-FELDHAUS, J., LIU, Q., HARSHMAN, K., TAVTIGIAN, S.V., STOCKERT, E., DAY III, R.S., JOHNSON, B.E. and SKOLNICK, M.H., A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440 (1994).
19. KOBAYASHI, K., MATSUSHIMA, M., KOI, S., SAITO, H., SAGAE, S., KUDO, R. and NAKAMURA, Y., Mutational analysis of mismatch repair genes, hMLH1 and hMSH2, in sporadic endometrial carcinomas with microsatellite instability. Jpn. J. Cancer Res., 87, 141-145 (1996).
20. LEE, J.H., KAVANAGH, J.J., WILDRICK, D.M., WHARTON, J.T. and BLICK, M., Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas. Cancer Res., 50, 2724-2728 (1990).
21. LI, S., SHWARTZ, P.E., LEE, W.-H. and YANG-FENG, T.L., Allele loss at the retinoblastoma locus in human ovarian cancer. J. nat. Cancer Inst., 83, 637-640 (1991).
22. Lo, K.-W., CHEUNG, S.-T. LEUNG, S.-F. VAN HASSELT, A., TSANG, Y.-S., MAK, K.-F. CHUNG, Y.-F., WOO, J.K.S., LEE, J. and HUANG, D.P., Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res., 56, 2721-2725 (1996).
23. INK4A-mediated growth suppression. Mol. cell. Biol., 16, 1047-1057 (1996).
24. MERLO, A., HERMAN, J.G., MAO, L., LEE, D.J., GABRIELSON, E., BURGER, P.C., BAYLIN, S.B. and SIDRANSKY, D., 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/ CDKN2/MTS1 in human cancers. Nature (Med.), 1, 686-692 (1995).
25. NOBORI, T., MIURA, K., WU, D.J., LOIS, A., TAKABAYASHI, K. and CARSON, D. A., Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368, 753-756 (1994).
26. OKAMOTO, A., SAMESHIMA, Y., YOKOYAMA, S., TERASHIMA, Y., SUGIMURA, T., TFRADA, M. and YOKOTA, J., Frequent allelic losses and mutations of the p53 gene in human ovarian cancer. Cancer Res., 51, 5171-5176 (1991).
27. ORLOW, I., LACOMBE, L., HANNON, G.J., SERRANO, M., PELLICER, I., DALBAGNI, G., REUTER, V.E., ZHANG, Z.-F., BEACH, D. and CORDON-CARDO, C., Detection of the p16 and p15 genes in human bladder tumors. J. Nat. Cancer Inst., 87, 1524-1529 (1995).
28. OWEN, D. and KUEHN, L.C., Noncoding 3′ sequences of the transferrin receptor gene are required for mRNA regulation by iron. EMBO J., 6, 1287-1293 (1987).
29. SATO, T., SAITO, H., MORITA, R., KOI, S., LEE, J.H. and NAKAMURA, Y., Allotype of human ovarian cancer. Cancer Res., 51, 5118-5122 (1991).
30. SERRANO, M., HAANON, G.J. and BEACH, D., A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366, 704-707 (1993).
31. SHELLING, S.N., COOKE, I.E. and GANESAN, T.S., The genetic analysis of ovarian cancer. Oncogene, 11, 521-527 (1995).
32. STONE, S., DAYANANTH, P., JIANG, P., WEAVER-FELDHAUS, J.M., TAVTIGIAN, S.V., CANNON-ALBRIGHT, L. and KAMB, A., Genomic structure, expression and mutational analysis of the p15 (MTS2) gene. Oncogene, 11, 987-991 (1995).
33. TANGIR, J., LOUGHRIDGE, N.S., BERKOWITZ, R.S., MUTO, M.G., BELL, D.A., WELSH, W.R. and MOK, S.C., Frequent microsatellite instability in epithelial borderline ovarian tumors. Cancer Res., 56, 2501-2505 (1996).
34. WASHIMI, O., NAGATAKE, M., OSADA, H., UEDA, R., KOSHIKAWA, T., SEKI, T., TAKAHASHI, T. and TAKAHASHI, T., In vitro occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers. Cancer Res., 55, 514-517 (1995).